The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Linlin Bao(Chinese Academy of Medical Sciences & Peking Union Medical College), Chuan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College)
Nature
May 7, 2020
10.1038/s41586-020-2312-y
Cited by 1,230

Related Papers

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
|Cell|2020|1.4k
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
|Viruses|2019|1.3k
Animal models for COVID-19
|Nature|2020|877
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
|The Journal of Infectious Diseases|2015|623
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
|The Journal of Infectious Diseases|2015|472